3. Frailty and Aging. 3.1. Healthy aging biological mechanisms oriented to the maintenance of functional autonomy and mechanisms leading to frailty and disability. CICERFES
Datos básicos
- Código:
- CB16/10/00282
- Dotación:
- 64.000,00 €
- Año inicial:
- 2017
- Año final:
- 2022
Documentos
- No hay documentos
Participantes
Financiadores
Resultados del Proyecto
Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis
Lopez-Fabuel, I; (...); Bolanos, JP
Article. 10.1038/s41467-022-28191-1. 2022
Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour
Vicente-Gutierrez, C; (...); Bolanos, JP
Article. 10.1016/j.redox.2021.101917. 2021
Astrocyte-neuron metabolic cooperation shapes brain activity
Bonvento, G, Bolanos, JP
Review. 10.1016/j.cmet.2021.07.006. 2021
Brightness and shadows of mitochondrial ROS in the brain
Jimenez-Blasco, D, Almeida, A, Bolanos, JP
Article. 10.1016/j.nbd.2023.106199. 2023
Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition
Morant-Ferrando, B; (...); Bolanos, JP
Article. 10.1038/s42255-023-00835-6. 2023
gamma-Linolenic acid in maternal milk drives cardiac metabolic maturation
Paredes, A; (...); Ricote, M
Article. 10.1038/s41586-023-06068-7. 2023
p38 gamma and p38 delta regulate postnatal cardiac metabolism through glycogen synthase 1
Santamans, AM; (...); Sabio, G
Article. 10.1371/journal.pbio.3001447. 2021
Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies
del Olmo, E; (...); San Feliciano, A
Article. 10.1016/j.bioorg.2024.107255. 2024
Preconditioning-Activated AKT Controls Neuronal Tolerance to Ischemia through the MDM2-p53 Pathway
Barrio, E; (...); Delgado-Esteban, M
Article. 10.3390/ijms22147275. 2021
Transcriptomic and metabolic signatures of neural cells cultured under a physiologic-like environment
Article. 10.1016/j.jbc.2024.107937. 2024
Cita
3. Frailty and Aging. 3.1. Healthy aging biological mechanisms oriented to the maintenance of functional autonomy and mechanisms leading to frailty and disability. CICERFES. (CB16/10/00282). Instituto de Salud Carlos III. 2017IP:Juan Pedro Bolaños Hernández.
3. Frailty and Aging. 3.1. Healthy aging biological mechanisms oriented to the maintenance of functional autonomy and mechanisms leading to frailty and disability. CICERFES. (CB16/10/00282). Instituto de Salud Carlos III. 2017IP: Juan Pedro Bolaños Hernández.